Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Date:2/21/2013

ty and efficacy of LX1033 in approximately 360 IBS-d patients. Lexicon also received Fast Track status from the FDA for the development of LX1033 in IBS-d.
  • Other Programs: Lexicon obtained results from Phase 1 studies of  LX2931, an inhibitor of sphingosine-1-phosphate lyase, in patients with rheumatoid arthritis, and LX7101, an inhibitor of LIM domain kinase 2 (LIMK2), in patients with glaucoma.  Both compounds were well-tolerated and showed signals of clinical benefit in the respective studies.
  • Financial ResultsRevenues:  Lexicon's revenues for the three months ended December 31, 2012 decreased 36 percent to $0.2 million from $0.3 million for the corresponding period in 2011. For the year ended December 31, 2012, revenues decreased 41 percent to $1.1 million from $1.8 million for the corresponding period in 2011.

    Research and Development Expenses:  Research and development expenses for the three months ended December 31, 2012 decreased 25 percent to $21.0 million from $28.1 million for the corresponding period in 2011, primarily due to a decrease in external manufacturing, clinical research and development costs. For the year ended December 31, 2012, research and development expenses decreased 10 percent to $82.6 million from $91.8 million for the corresponding period in 2011.

    Increase (Decrease) in Fair Value of Symphony Icon Purchase Liability:  In connection with the acquisition of Symphony Icon, Lexicon made an initial estimate of the fair value of the liability for the associated base and contingent payments. Changes in this liability, based on the development of the programs and the time until such payments are expected to be made, are recorded in Lexicon's consolidated statements of operations. For the three months ended December 31, 2012, the fair value of the Symphony Icon purchase liability decreased by $0.2 million, compared to an increase of $1.6 million in the corresponding period in 2011. For
    '/>"/>

    SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Lexicon To Present At The BIO CEO & Investor Conference
    2. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
    3. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
    4. Lexicon to Provide Third Quarter 2012 Financial Results
    5. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
    6. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
    7. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
    8. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
    9. Lexicon to Provide Second Quarter 2012 Financial Results
    10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
    11. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... the medical, research, and veterinary markets worldwide and providing ... in the United States , announced ... acquire 100% of QCR & Trio Diagnostics Limited, a ... The transaction closed on November 17, 2014. ...
    (Date:11/21/2014)... MELVILLE, N.Y. , Nov. 21, 2014 ... one of the world,s largest health care services companies, ... the world,s largest provider of health care products and ... today announced that the companies have entered into a ... comprehensive service and product offerings to office-based medical practices.  ...
    (Date:11/21/2014)... BRYDGES, Ontario , Nov. 20, 2014 /PRNewswire/ ... monitor mounting solutions and reading room environment guidance, ... their newest musculoskeletal radiology reading room, which may ... room designs at Penn Medicine. ... by the American College of Radiology,s Imaging 3.0 ...
    Breaking Medicine Technology:Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3
    ... 2011 PDI, Inc. (Nasdaq: PDII ) ... DIAGRAM™ software platform to enable eDetail delivery on popular ... ® and iPhone ® (1) and Android™(2)-based phones. ... devices even faster than the general population, we are ...
    ... April 25, 2011 Pharmatek Laboratories, Inc., a ... pharmaceutical industry, announced that it has added spray ...  The company has purchased a Buchi B-290 Mini ... clinical manufacture.  This technology can be used for ...
    Cached Medicine Technology:PDI Announces Group DCA's Launch of eDetailing Across Apple® and Android™ Mobile Devices 2Pharmatek Laboratories Adds Spray Drying to Drug Development Services 2
    (Date:11/21/2014)... Seeking to make it tougher for people to misuse ... Thursday approved a new hydrocodone tablet that,s designed to ... the brand name Vicodin -- is a powerful opioid ... dangerous addictions across the United States. The FDA ... an extended-release tablet to treat pain severe enough to ...
    (Date:11/21/2014)... November 21, 2014 MLF Biotech, Inc. ... cats . Liv-Pro® Probiotics for Pets helps maintain digestive ... to a pet's intestinal flora after it experiences a ... , Liv-Pro Probiotics for Pets is a proprietary blend ... contains seven live active bacteria strains that are safe ...
    (Date:11/21/2014)... NJ (PRWEB) November 21, 2014 The ... homemade, high calorie dishes, plenty of gravy and a ... could be the best time of year to begin ... Diet Doc has uncovered the secret to losing unhealthy, ... the fattening holiday recipes. , The insight to Diet ...
    (Date:11/21/2014)... Lauderdale, Florida (PRWEB) November 21, 2014 ... for chronic headaches and other jaw-related symptoms, ... patients seeking relief from chronic head pain, neck pain, ... , “This year we have seen a 52% ... treated. Our network of over 300 doctors and their ...
    (Date:11/21/2014)... Even with years of experience under his belt, Kirk ... growth, participating in two recent events for his State Farm ... networking event with the leaders of State Farm and thousands ... and greatest in insurance news and products for his clients. ... (Stacy, Anthony, Reina and Jacob) as exhibitors at the recent ...
    Breaking Medicine News(10 mins):Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:National Rise In Patients Seeking Headache Relief 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2
    ... stroke patients have not had a great track record ... Zealand focused on Maori and Pacific populations shows how ... and families in charge can make a difference to ... in the journal Clinical Rehabilitation , which is ...
    ... , TUESDAY, Nov. 15 (HealthDay News) -- Dieters appear to ... weight-loss counseling, two different studies suggest. Even if that ... can translate to more weight loss, the experts found. Either ... studies will be presented this week at the American Heart ...
    ... Nov. 15 (HealthDay News) --,Pneumonia is the most common infection ... also revealed that most infections occur about two weeks after ... are slated to present their findings Tuesday at the American ... not what we expected to find," study author Dr. Michael ...
    ... screening may increase awareness of the dangers of smoking and ... November 2011 issue of Otolaryngology-Head and Neck Surgery . ... 80% of head and neck cancers could be curbed by ... to date have had little impact reducing these mortalities. ...
    ... Disease Control and Prevention (CDC) has awarded Mayo Clinic ... in Ethiopia. The five-year award will support Mayo Clinic ... develop online education courses that disseminate best practices and ... The HIV eCurriculum project will be led by ...
    ... process. An early sign that it has begun is high ... insulin-producing beta cells are able to compensate for the increased ... sugar levels remain normal. It is not until the capacity ... 2 diabetes becomes a fact. The latter stage generally goes ...
    Cached Medicine News:Health News:Putting stroke patients in charge improves quality of life 2Health News:Putting stroke patients in charge improves quality of life 3Health News:Looking to Lose Weight? Get a 'Coach' 2Health News:Looking to Lose Weight? Get a 'Coach' 3Health News:Pneumonia Most Common Infection After Heart Surgery 2Health News:Population-specific community-based cancer screening may discourage smoking 2Health News:CDC and Prevention awards Mayo Clinic an international medical education grant 2Health News:Molecular link between diabetes and cancer described 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: